XML 21 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net (Loss) Income $ (20,368,808) $ 18,860,835
Adjustments to reconcile net (income) loss to net cash used by operating activities:    
Stock based compensation 807,523 1,391,271
Restricted stock expense 1,137,583 138,001
Marketing stock amortization 660,232 0
Issuance of stock / warrants for service 98,605 84,450
Inventory and materials impairment 0 233,372
Impairment on discontinued operations asset 0 45,783
Depreciation and amortization 719,856 499,394
Other than temporary impairment other securities and other accounts receivable 0 760,000
Increase/(Decrease) in contingent liability 10,500,000 (30,580,000)
Realized and unrealized loss of Marketable and other securities (526,939) 146,011
Merchant reserve settlement 0 132,657
Termination benefit 495,568 0
Extinguishment of Paycheck Protection Program Loan (1,466,113) 0
Amortization of operating lease asset 922,057 878,986
Changes in operating assets and liabilities:    
Accounts receivable (556,116) 710,629
Merchant reserve 0 386,912
Deposits 261,125 (147,166)
Inventory (135,058) (2,329,112)
Prepaid inventory (385,410) 621,573
Prepaid expenses and other current assets (141,393) 1,007,374
Accounts payable and accrued expenses (603,216) (480,424)
Operating lease liability (846,914) (766,289)
Note payable 0 42,968
Deferred revenue / customer deposits 4,478 (7,339)
Collection on discontinued operations accounts receivable 428,667 333,333
Deferred tax liability (765,000) (2,240,300)
Cash used by operating activities (9,759,273) (10,277,081)
Cash flows from investing activities:    
Proceeds from sale of other investment securities (540,000)  
Purchase of other investment securities (750,000) 0
Purchase of property and equipment (311,572) (1,851,746)
Cash provided (used) by investing activities (521,572) (1,851,746)
Cash flows from financing activities:    
Proceeds from issuance of common stock 0 16,771,756
Proceeds from issuance of preferred stock 15,798,115 4,421,928
PPP loan 0 1,456,100
Note payables (137,292) 0
Preferred dividend distribution (1,220,610) (266,800)
Deferred Issuance costs 0 62,197
Cash provided by financing activities 14,440,213 22,445,181
Net increase (decrease) in cash 4,159,368 10,316,354
Cash and cash equivalents, beginning of period 14,824,644 4,689,966
Cash and cash equivalents, end of period 18,984,012 15,006,320
Cash Payments for:    
Interest expense 23,573 26,126
Non-cash financing activities:    
Issuance of Contingent earnout shares: 12,596,089 0
Warrants issued to representative $ 254,950 $ 524,113